EP3544621A1 BicycleRD Limited Cancer Treatment Methods
Summary
The EPO published application EP3544621A1 on April 15, 2026, covering methods for treating cancer using bicyclic peptides. The applicant is BicycleRD Limited and the named inventors are BENNETT, Gavin and TEUFEL, Daniel Paul. The application classifies under IPC codes A61K 38/00 (medicinal preparations containing peptides) and A61P 35/00 (antineoplastic agents). The designated states cover all major European Patent Convention member countries including DE, FR, GB, NL, SE, and 27 additional contracting states.
About this source
GovPing monitors EPO Patent Bulletin - Therapeutics (A61P) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 17 changes logged to date.
What changed
The EPO published patent application EP3544621A1, a new patent filing for methods of treating cancer using bicyclic peptide technology. The application names BicycleRD Limited as the applicant and BENNETT, Gavin and TEUFEL, Daniel Paul as the inventors. Classification falls under A61K (medicinal preparations) and A61P 35/00 (antineoplastic/anticancer therapeutics).
Pharmaceutical and biotechnology companies operating in the oncology space should note this filing as it may represent potential freedom-to-operate considerations. Competitors developing bicyclic peptide-based cancer therapies should review the patent claims upon grant to assess any overlap with their own research programmes.
Archived snapshot
Apr 22, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
METHODS FOR TREATING CANCER
Publication EP3544621A1 Kind: A1 Apr 15, 2026
Applicants
BicycleRD Limited
Inventors
BENNETT, Gavin, TEUFEL, Daniel Paul
IPC Classifications
A61K 38/00 20060101AFI20180601BHEP A61P 35/00 20060101ALI20180601BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.